Epilepsy Trial, Recruiting (NCT03912155)

Epilepsy Trial, Recruiting NCT03912155 Sponsor: Assistance Publique Hopitaux De Marseille Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT03912155 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are having electrodes placed inside the brain as part of an assessment to see if surgery could help with epilepsy that has not responded to medication.
People (or their legal representative) who have been informed about the trial and have agreed to take part.
People who are already receiving medical follow-up care as part of their treatment.
Control subjects (people without epilepsy) who have been informed about the trial and have agreed to take part, or whose legal representative has agreed on their behalf.
All participants must be covered by a social security (health insurance) scheme.

Who may not be able to join:

Children under 12 years of age.
Women who are pregnant or breastfeeding.
Adults who are under legal guardianship or under the protection of the justice system.
People who are not covered by a social security scheme.
People who are deprived of their liberty by a court or administrative decision.
People who have not given informed consent to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jean-Olivier ARNAUD, Director, Assistance Publique Hôpitaux de Marseille

Phone: 491384995

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03912155

Sponsor: Assistance Publique Hopitaux De Marseille

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: 491384995

More information: https://clinicaltrials.gov/study/NCT03912155

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are having electrodes placed inside the brain as part of an assessment to see if surgery could help with epilepsy that has not responded to medication.
People (or their legal representative) who have been informed about the trial and have agreed to take part.
People who are already receiving medical follow-up care as part of their treatment.
Control subjects (people without epilepsy) who have been informed about the trial and have agreed to take part, or whose legal representative has agreed on their behalf.
All participants must be covered by a social security (health insurance) scheme.

Who may not be able to join:

Children under 12 years of age.
Women who are pregnant or breastfeeding.
Adults who are under legal guardianship or under the protection of the justice system.
People who are not covered by a social security scheme.
People who are deprived of their liberty by a court or administrative decision.
People who have not given informed consent to participate.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Assistance Publique Hopitaux De Marseille

Registry

ClinicalTrials.gov

Start date

15 April 2019

Est. completion

15 April 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Rate of epileptic discharges; Rate of epileptic discharges; Rate of epileptic discharges

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov